Showing results (991-1000 of 2,413) with videos related to
Sort By:
Pageof 242
Journal of Medical Economics|May 17, 2019
Budget impact of netupitant/palonosetron for the prevention of chemotherapy-induced nausea and vomitingSang Hee Park, Gary Binder, Shelby Corman, et al.Journal of Medical Economics|May 17, 2019
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FPJoanna Davis, Songkai Yan, Tadashi Matsushita, et al.Journal of Medical Economics|April 24, 2019
An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United StatesSandra Milev, Marco daCosta DiBonaventura, Peter Quon, et al.Journal of Medical Economics|April 24, 2019
Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United StatesArielle G Bensimon, Zheng-Yi Zhou, Madeline Jenkins, et al.Journal of Medical Economics|April 13, 2019
Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel surveyJanet H Ford, Wenyu Ye, Russell M Nichols, et al.Journal of Medical Economics|August 21, 2018
Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemiaMay Hagiwara, Arati Sharma, Karen C Chung, et al.Journal of Medical Economics|May 4, 2019
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness studyGregory F Guzauskas, Erqi L Pollom, Volker W Stieber, et al.Journal of Medical Economics|February 2, 2022
The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitusRichard F Pollock, Kirsi Norrbacka, Kristina S Boye, et al.Journal of Medical Economics|February 4, 2022
Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United StatesAmie Scott, Richard Chambers, Maya Reimbaeva, et al.Journal of Medical Economics|February 7, 2022
Evaluating the cost utility of racecadotril in addition to oral rehydration solution versus oral rehydration solution alone for children with acute watery diarrhea in four low middle-income countries: Egypt, Morocco, Philippines and VietnamTamlyn Anne Rautenberg, Martin Downes, Pham Huy Tuan Kiet, et al.Pageof 242